Part 1 in our series details the process of turning a patent application into a granted patent in the United States, and Part 2 will outline the process of obtaining patent protection in other ...

NESS ZIONA, Israel, June 3, 2021 /PRNewswire/ — MeaTech 3D Ltd. (NASDAQ: MITC) (TASE: MITC), a technology company developing a suite of advanced manufacturing technologies to produce cultured meat ...

“Refiling a provisional is just a bad idea when you can, for a few hundred dollars more, keep hold of that earliest priority date and continue on the path to obtaining a patent.” The question that we ...

Patent applicants often file provisional applications at the United States Patent and Trademark Office (USPTO) to secure a priority date before filing a full-blown utility patent application for their ...

Integrated Cyber Solutions Inc. (CSE: ICS) (OTCQB: IGCRF) (FSE: Y4G) dba Integrated Quantum Technologies ("IQT" or the ...

Provisional patent applications are patent applications filed with the United States Patent and Trademark Office (USPTO). but not examined by it. They are placeholders, establishing a patent filing ...

As part of the effort to harmonize global patent systems, the United States introduced the provisional patent application in 1995 as part of the GATT Uruguay Round agreement. The provisional patent ...

PITTSBURGH, July 28, 2022 (GLOBE NEWSWIRE) -- Montauk Renewables, Inc. (“Montauk” or “the Company”) (NASDAQ: MNTK), a renewable energy company specializing in the management, recovery and conversion ...

If you come to a patent attorney with a provisional that you filed pro se or used a cheap online service and ask the attorney to file the utility, you may already be behind the eight ball. You have a ...

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Raphael Pharmaceutical Inc. (“Raphael Pharmaceutical” or the “Company”) (OTCQB: RAPH) , a clinical-stage biotechnology company developing an innovative ...

Continued expansion of IP portfolio related to RNA delivery Treatment of rheumatoid arthritis as one of the key therapeutic indications HAMILTON, BERMUDA / May 1, 2024 / Altamira Therapeutics Ltd.